NCT01395550View on ClinicalTrials.gov

Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event

CompletedOBSERVATIONAL
Enrollment

88

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Cardiovascular Events
Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY